Columbia Laboratories to Present at the ROTH Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California on February 20, 2008

LIVINGSTON, NJ— February 11, 2008 — Robert S. Mills, president and chief executive officer of Columbia Laboratories, Inc., (NASDAQ: CBRX) will present at the ROTH Capital Partners 20th Annual OC Growth Stock Conference.

Date: Wednesday, February 20, 2008
Time: 4:00 p.m. Pacific Time
Venue: Ritz Carlton Laguna Niguel in Dana Point, California
Live webcast: www.cbrxir.com, under “Events”

This presentation will be archived for 90 days on Columbia Laboratories’ investor website, www.cbrxir.com, under “Events.”

About Columbia Laboratories

Columbia Laboratories, Inc. is a is a specialty pharmaceutical company focused on developing and marketing products for the women’s healthcare and endocrinology markets using its novel bioadhesive drug delivery technology. Columbia markets CRINONE^® 8% (progesterone gel) and PROCHIEVE^® 8% (progesterone gel) in the United States for progesterone supplementation as part of an Assisted Reproductive Technology treatment for infertile women with progesterone deficiency. The Company also markets STRIANT^® (testosterone buccal system) for the treatment of hypogonadism in men. The Company’s research and development programs include a vaginal lidocaine product to prevent and treat dysmenorrhea and PROCHIEVE to reduce the risk of preterm birth in women with a short cervix in mid-pregnancy. For more information, please visit www.columbialabs.com.